Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Omnicell, Inc.

Market Cap 1.81B 1.56B 1.44B 1.35B 2.54B 172B 2.57B 17.02B 6.63B 84.01B 6.81B 6.67B 291B P/E Ratio 2026 *
51.2x
P/E Ratio 2027 * 40.4x
Enterprise Value 1.81B 1.56B 1.44B 1.35B 2.54B 172B 2.57B 17.02B 6.63B 84.01B 6.81B 6.67B 291B EV / Sales 2026 *
1.45x
EV / Sales 2027 * 1.38x
Free-Float
76.29%
Yield 2026 *
-
Yield 2027 * -
1 day+1.18%
1 week-2.86%
Current month-9.57%
1 month-7.10%
3 months+15.65%
6 months-10.05%
Current year-12.37%
1 week 32.2
Extreme 32.2
34.2
1 month 32.2
Extreme 32.2
38
Current year 28
Extreme 28
43.8
1 year 22.8
Extreme 22.8
43.8
3 years 21.6
Extreme 21.6
67.5
5 years 21.6
Extreme 21.6
162
10 years 21.6
Extreme 21.6
162
Manager TitleAgeSince
Chief Executive Officer 68 2002-09-30
Director of Finance/CFO 56 2025-09-14
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 68 1992-08-31
Director/Board Member 70 2012-12-31
Director/Board Member 70 2013-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%-2.86% - - 1.81B
+0.75%-2.56%-42.59%-18.33% 26.54B
+2.66%+4.18%-38.11%+145.79% 12.13B
-1.64%-5.96%-9.51%+51.66% 5.9B
-2.35%+11.79% - - 2.76B
-1.55%+1.36% - - 1.71B
-0.58%+4.91%-29.28% - 1.33B
+0.28%-4.30%-33.71%-59.45% 816M
+0.56%-0.46%-29.11%+220.30% 790M
-0.21%-1.09%-35.55%-41.89% 713M
Average -0.10%+0.75%-31.12%+49.68% 5.86B
Weighted average by Cap. +0.63%-0.95%-36.57%+35.88%

Financials

2026 *2027 *
Net sales 1.25B 1.07B 990M 929M 1.74B 118B 1.76B 11.7B 4.56B 57.75B 4.68B 4.58B 200B 1.32B 1.13B 1.04B 980M 1.84B 124B 1.86B 12.33B 4.8B 60.9B 4.94B 4.83B 211B
Net income 35.72M 30.78M 28.34M 26.61M 49.97M 3.38B 50.49M 335M 130M 1.65B 134M 131M 5.73B 45.83M 39.49M 36.37M 34.15M 64.11M 4.33B 64.79M 430M 167M 2.12B 172M 168M 7.35B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,525
Date Price Change
26-06-16 34.00 -0.58%
26-06-15 34.20 +6.21%
26-06-12 32.20 -1.23%
26-06-11 32.60 -5.78%
26-06-10 34.60 -1.14%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
39.90USD
Average target price
61.29USD
Spread / Average Target
+53.60%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!